Bioethics of clinical innovation and unproven methods

Conference organised by the Nordic Committee on Bioethics in collaboration with Centre for Legal Studies in Welfare and Market at the University of Copenhagen, 9 April 2019.

Tid og sted


Alf Ross auditorium (room 9A-3-01), Faculty of Law, University of Copenhagen, Karen Blixens Plads 16, 2300 Copenhagen S. 09.04.2019 fra 09:00 til 17:00

How are clinical innovations and unproven methods developed and introduced in western Nordic health-care systems? What is the legal and regulatory environment concerning unproven methods in medicine? What ethical principles should guide work on emerging treatments and experimentation in hospitals? In the upcoming NCBio-conference, these three questions will each be addressed in separate sessions.

Clinical innovation involves development of new techinques, methods, treatments and diagnostics for detecting, alleviating and curing diseases. By nature novel clinical methods and treatments are unproven when first developed. Through the centuries, medicine has advanced by trials and errors of physicians and researchers experimenting with treatments and methods. The failure of certain methods are inseperable from success of others, because a priori it is hard to know what works and what not. The scientific method is the preferred approach to develop cures and treatments, but many current medical practices were not developed by strict scientific testing or trials. Healthcare professionals may try unproven methods, for instance as a last resort in attempt to safe a life. Such unproven methods for clinics and health care, occur at the intersect of basic research and standard health-care and raise number of bioethical issues. Those include the following issues. Do patients have sufficient and equal access to the experimental methods? Are patients protected from harm when unproven methods are tested? Who should make decisions about when to experiment with a treatment? How can society and the health care system best simultaneously promote clinical innovation and protect patients?

Meld deg på her


Mer informasjon om denne hendelsen…

Marianne Aastebøl Minge - Leder for operativ virksomhet
Kontaktperson Marianne Aastebøl Minge
Leder for operativ virksomhet
Work +47 936 02 527
Anna Herou - Seniorrådgiver
Kontaktperson Anna Herou
Work +47 480 63 139